Miromatrix Medical Inc. and its directors allegedly misled investors about a pending $91 million acquisition by United Therapeutics Corp., according to a shareholder lawsuit.
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.